Activation of the Alternative Complement Pathway by Fonsecaea pedrosoi  by Torinuki, Wakio et al.
0022-202X/84/8304-0308$02.00/0 
TBE JO URNA L OF I NVESTI(:ATIVE DERMATOLOGY , 83:308- 310, 1984 
Copyright © 1984 by The Williams & Wilkins Co. 
Vol. 83, No. 4 
Printed in U.S.A . 
Activation of the Alternative Complement Pathway by Fonsecaea 
pedrosoi 
WAKIO TORINUKI, M.D., KYOKO 0KOHCHI, M.D., HIDEAKI TAKEMATSU, M.D., AND 
HACHIRO TAGAMI, M.D. 
Department of Dermatology, Tohoku University School of Medicine, Sendai, Japan 
Human sera were examined for evidence of comple-
ment activation by Fonsecaea pedrosoi. The serum that 
had been incubated with F . pedrosoi showed immunoe-
lectrophoretic C3 conversion and generation of C5a, as 
measured by radioimmunoassay. C3 conversion and C5a 
generation did not occur in serum chelated with EDT A, 
or in serum heated to 56°C for 30 min. Serum depleted 
of the heat (50°C x 30 min)-labile factor B was also 
deficient in C3 conversion and C5a generation. Comple-
ment activation was not affected when the classical 
pathway was blocked by Mg++_EGTA. These studies 
indicate that F. pedrosoi can activate the complement 
system via the alternative pathway, with the resultant 
development of C5a. 
Chromoblastomycosis is a chronic mycotic infection pro-
duced by a variety of dematiaceous fungi . It is clincally char-
acterized by the formation of verrucous nodules or plaques on 
the skin . Histopathologically, the dermis shows extensive cel-
lular infiltration with a polymorphous granulation tissue con-
taining many multinucleated giant cells and microabscesses 
composed of neut rophils (Fig 1). One of the primary defense 
mechanisms of the host against infectious organisms is the 
ability to mobilize leukocytes to the site of infection. Comple-
ment is an important factor in the serum that operates to 
induce such leukocyte chemotaxis as well as opsonization of 
the organisms. It has been shown that complement is directly 
activated by a variety of fungi including Candida albicans [1], 
dermatophytes [2,3] and others [ 4-7] in the absence of specific 
antibodies. Since there is neutrophilic infiltration as well as 
formation of microabscesses in the lesions of chromoblasto-
mycosis and since Fonsecaea pedrosoi is the most common 
causative organism of such infiltration in Japan [8], we per-
formed the present study to verify whether F. pedrosoi is 
capable of activating complement in vitro as are other patho-
genic fungi. 
MATERIALS AND METHODS 
Homogenate of F. pedrosoi 
Sabouraud 's dextrose agar containing chloramphenicol (100 1-'g/ ml) 
was chosen as the culture medium. Strains of F. pedrosoi were isolated 
from 4 cases of chromoblastomycosis that have been reported in detail 
elsewhere [9]. F. pedrosoi was grown on the medium at 27•C for 4 
weeks. Twenty-th ree milligrams of the resultant fungal colony were 
washed well in and suspended in 1 ml of phosphate-buffered saline 
(PBS, pH 7.2), boiled for 30 min, and finally homogenized by means of 
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a Polytron homogenizer for 5 min. The resultant homogenate was used 
for complement activation of serum. 
Activation of Serum Complement 
Sera were obtained on the day of study from healthy persons. 
Aliquots of sera were depleted of complement activity by heat (56•C x 
30 min) . Factor B-depleted serum was prepared by heating serum to 
5o·c for 30 min. In chelator studies, serum was chela ted by the addition 
of 1/10 volume of 0.1 M ethyleneglycol-bis(J)-amino-ethyl ether)N,N'-
tetraacetic acid (EGTA) supplemented with 10 mM Mg++ or 0.1 M 
EDTA in verona! buffer (pH 7.4). One volume of the homogenate of F. 
pedrosoi was added to 5 volumes of serum treated as mentioned above, 
and incubated (37•C x 60 min) with agitation. After centrifugation, 
the resultant supernatant was used for C3 immunoelectrophoresis and 
C5a radioimmunoassay. Serum activated with zymosan (25 mg/ml of 
serum; Sigma Chemical Co., USA) was used as a positive control for 
complement activation. Parallel to this, normal serum incubated with 
PBS alone was used as a negative control. 
Immunoelectrophoresis 
C3 immunoelectrophoresis was performed on microscope slides using 
1% agarose (Agarose-l; Wako Pure Chemical Co., Japan) in verona! 
buffer (pH 8.6, ionic strength = 0.05) with a continuous potential 
gradient of 2 rnA/em for 4 hat 4 ·c. Goat antiserum to human C3 ({31C/ 
{j,A) was obtained from Miles Laboratories Inc., USA. Each serum 
sample was incubated at 56·c for 30 min before immunoelectrophoresis 
to prevent complement activation by the agarose gel. 
Radioimmunoassay for C5a and C5a des Arginine 
Radioimmunoassay for C5a and C5a des arginine was performed 
according to the method described by Hugli and Chenoweth [10]. The 
assay kit for C5a des arginine was purchased from Upjohn Diagnostics 
(A Division of Upjohn Company, Michigan, USA). The methodology 
of this kit is selective for C5a and C5a des arginine, eliminating assay 
interference from CS. 
RESULTS 
C3 Conversion 
For direct demonstration of complement activation, evidence 
for C3 conversion in serum was sought immunoelectrophoreti-
cally. Incubation of heat-killed F. pedrosoi in normal human 
serum or Mg++_EGTA-chelated serum resulted in the immu-
noelectrophoretic conversion of C3 from {3 1C to {3 1A. A similar 
pattern was observed in zymosan-activated serum. However, 
such an extra precipitin peak was absent from PBS-treated 
serum. Complement conversion was eliminated in EDTA-che-
lated serum, or in serum heated to so·c or 56·c for 30 min. 
These results are shown in Fig 2. 
Measurement of C5a and C5a des Arginine 
The results of quantitative determination by radioimmu-
noassay of C5 cleavage products consisting of C5a and its des 
arginine derivative are shown in Table I. Incubation of F. 
pedrosoi suspension with normal human serum or Mg++-
EGTA-chelated serum led to the production of C5a and C5a 
des arginine. This increment in C5 cleavage products was still 
moderate in degree as compared to that noted in zymosan-
activated serum which showed prominent C5a production ex-
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FIG 1. Histopathology of the skin lesion of chromoblastomycosis. 
There is a mixed cell granulomatous change containing numerous 
neutrop hi ls around fun gal cells (arrow). 
1 
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FIG 2 . Immunoelectrophoresis using goat antihuma n C3. Troughs 
contain a nti -C3 ant iserum ; wells conta in test se ra, 1 = Normal human 
serum+ F. pedrosoi. 2 = Mg++_EGTA-chelated serum+ F. pedroso£. 3 
, Normal huma n serum + PBS. 4 = EDTA -chelated serum + F. 
pedrosoi. 5 = Zymosan-activated serum . 6 = Heated ~erum (56:C X 30 
min) + F. pedroso1. 7 = Factor B-depleted serum (50 C x 30 mm) + F. 
pedrosoi. 
ceeding the measurement range of this radioimmunoassay. In 
contrast, the occurrence of C5 cleavage could be eliminated_ in 
sera depleted of complement activity by heat (56oC X 30 mm) 
or EDT A. There was also no generation of C5a and C5a des 
arginine in factor B-depleted serum (50oC X 30 min). 
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TABLE I. Radioimmunoassay for estimating C5a. and C5a des arginine 
ng (C5a + C5a des arginine)/ ml 
of serum 
PBS + normal human serum 
F. pedrosoi + normal human serum 
F. pedrosoi + EDTA -chelated serum 
F. pedrosoi + Mg++.EGTA-chelated 
serum 
F. pedrosoi + heated serum 
(56·c x 30 min) 
F. pedrosoi + factor B-depleted serum 
(50•C X 30 min) 
Zymosan-activated serum 
Mean of duplicate measurements. 
DISCUSSION 
0 
286.7 
0 
270.4 
0 
0 
>532.0 
The role of complement in many fungal infections remains 
largely unclear. In this report, we have presented data indica-
ting that the incubat ion of serum with F. pedrosoi induces 
activation of the alternative complement pathway, which, in 
turn, results in the development of chemotactic anaphylatoxin (C5a). A variety of substances derived from bacteria have been 
shown to cause migrat ion of neut rophils in vitro [11] . This 
complement activation is unlikely to have occurred due to 
bacterial contamination during preparation, because only the 
fungus was grown in the presence of antibacterial agents. 
Such complement activation by fungus is not unique to F. 
pedrosoi. It has been shown previously that complement is 
activated by a variety of fungi including Trichophyton rubru.m (3], T . mentagrophytes (2], Candida albicans [1], Cryptococcus 
neoforma.ns (4] and others [5-7]. Based on these facts, comple-
ment seems to play a critical role in t he development of tissue 
inflammation and defense against various fungal invaders. 
Accumulation of neutrophils is found around the spores as a 
histologic feature of chromoblastomycosis (Fig 1). Here we 
described an in vitro study of F. pedrosoi-induced C3 conversion 
and generation of a major chemoattractant, i.e. , C5a. Although 
the exact pathophysiology of t his leukocyte accumulation in 
the lesions of chromoblastomycosis remains unclarified, our 
findings suggest a mechanism in which direct activation of 
serum complement by F. pedrosoi results in the generation of 
potent chemoattractants. Complement activation generates 
several active mediators of inflammation, i.e., opsonins, ana-
phylatoxins, and chemoattractants, which enhance the direc-
tional migration and phagocytic function of neutrophils, ulti-
mately enhancing the killing of t he fungus. 
Although accumulation of neutrophils takes place, of course, 
we cannot overlook the importance of cell-mediated immune 
response in the host's defense against invading organisms. 
Microscopically, we fi nd a granulomatous tissue reaction in 
addition to neutrophil abscess in t he dermis of chromoblasto-
mycosis. In their study using athymic nude mice, Nishimura 
and Miyaji [12] demonstrated that phagocytosis caused by 
neutrophils and the granulomatous response induced by cell-
mediated immunity played importan t roles in the defense 
against the fungal invasion of t he t issues. It is reported that 
among patients infected with F. pedrosoi there is positive 
delayed skin reaction to the F. pedrosoi antigen [13]. 
In summary, in this study we have shown that F. pedrosoi 
activates the alte rnative complement pathway. We propose that 
complement may play a role in the inflammation of F. pedrosoi 
infection and defense against dematiaceous fungi. 
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